FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098481087> ?p ?o ?g. }

• W2098481087 endingPage "1718" @default.
• W2098481087 startingPage "1711" @default.
• W2098481087 abstract "This study aimed at providing an insight on the possible role of cannabinoid (CB) type 2 receptors (CB2R) and cGMP pathway in the antiepileptic activity of WIN 55,212-2, (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo[1,2,3-de]-1,4-benzoxazin-6-Yl]-1-naphthalenylmethanone, a non-selective CB agonist, in the maximal dentate activation (MDA) model of partial epilepsy in adult male rats. We evaluated the activity of a CB2 antagonist/inverse agonist AM630, [6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)methanone or 6-iodopravadoline, alone or in co-administration with WIN 55,212-2. Also, in the MDA model it was investigated the co-treatment of WIN 55,212-2 and 1H-[1,2,4]Oxadiazole[4,3-a]quinoxalin-1-one (ODQ), a specific inhibitor of the nitric oxide (NO)-activated soluble guanylyl cyclase (sGC), the cGMP producing enzyme. The WIN 55,212-2-dependent (21 mg/kg) antiepileptic effects were significantly increased by the co-administration with AM630 and by the co-treatment with ODQ (10 mg/kg). Whereas, the administration of AM630 (2 mg/kg), alone exerts no effects on hippocampal hyperexcitability. Our data show that pharmacological blockade of CB2 receptors and of sGC seems to cooperate with WIN in its antiepileptic action. These findings shed light on CB signaling mechanisms, hinting that the modulation of the effects of CB agonist in the hyperexcitability phenomena may be exerted both by targeting CB receptors and their possible downstream effectors, such as nitrergic-dependent cGMP pathway." @default.
• W2098481087 created "2016-06-24" @default.
• W2098481087 creator A5002018004 @default.
• W2098481087 creator A5016779008 @default.
• W2098481087 creator A5037205927 @default.
• W2098481087 creator A5045085140 @default.
• W2098481087 creator A5086995715 @default.
• W2098481087 creator A5089712382 @default.
• W2098481087 creator A5091227500 @default.
• W2098481087 date "2014-12-01" @default.
• W2098481087 modified "2023-09-24" @default.
• W2098481087 title "Role of CB2 receptors and cGMP pathway on the cannabinoid-dependent antiepileptic effects in an in vivo model of partial epilepsy" @default.
• W2098481087 cites W1512507748 @default.
• W2098481087 cites W1607650190 @default.
• W2098481087 cites W1654380405 @default.
• W2098481087 cites W1742914638 @default.
• W2098481087 cites W1824110706 @default.
• W2098481087 cites W1824502655 @default.
• W2098481087 cites W1887859390 @default.
• W2098481087 cites W1965769989 @default.
• W2098481087 cites W1965840063 @default.
• W2098481087 cites W1982441001 @default.
• W2098481087 cites W1989756472 @default.
• W2098481087 cites W1991497324 @default.
• W2098481087 cites W1993423020 @default.
• W2098481087 cites W1998171066 @default.
• W2098481087 cites W2004923981 @default.
• W2098481087 cites W2010600097 @default.
• W2098481087 cites W2020004376 @default.
• W2098481087 cites W2020808135 @default.
• W2098481087 cites W2028312992 @default.
• W2098481087 cites W2028727710 @default.
• W2098481087 cites W2029522113 @default.
• W2098481087 cites W2052559631 @default.
• W2098481087 cites W2062417095 @default.
• W2098481087 cites W2067208793 @default.
• W2098481087 cites W2068651039 @default.
• W2098481087 cites W2070592640 @default.
• W2098481087 cites W2075894678 @default.
• W2098481087 cites W2087154776 @default.
• W2098481087 cites W2093267069 @default.
• W2098481087 cites W2098199042 @default.
• W2098481087 cites W2115808149 @default.
• W2098481087 cites W2122465097 @default.
• W2098481087 cites W2124248227 @default.
• W2098481087 cites W2136798984 @default.
• W2098481087 cites W2146347032 @default.
• W2098481087 cites W2146526508 @default.
• W2098481087 cites W2155244384 @default.
• W2098481087 cites W2159556277 @default.
• W2098481087 cites W2165518874 @default.
• W2098481087 cites W2214256977 @default.
• W2098481087 cites W2414741422 @default.
• W2098481087 cites W333522424 @default.
• W2098481087 doi "https://doi.org/10.1016/j.eplepsyres.2014.10.001" @default.
• W2098481087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25458534" @default.
• W2098481087 hasPublicationYear "2014" @default.
• W2098481087 type Work @default.
• W2098481087 sameAs 2098481087 @default.
• W2098481087 citedByCount "32" @default.
• W2098481087 countsByYear W20984810872015 @default.
• W2098481087 countsByYear W20984810872016 @default.
• W2098481087 countsByYear W20984810872017 @default.
• W2098481087 countsByYear W20984810872018 @default.
• W2098481087 countsByYear W20984810872019 @default.
• W2098481087 countsByYear W20984810872020 @default.
• W2098481087 countsByYear W20984810872021 @default.
• W2098481087 countsByYear W20984810872022 @default.
• W2098481087 countsByYear W20984810872023 @default.
• W2098481087 crossrefType "journal-article" @default.
• W2098481087 hasAuthorship W2098481087A5002018004 @default.
• W2098481087 hasAuthorship W2098481087A5016779008 @default.
• W2098481087 hasAuthorship W2098481087A5037205927 @default.
• W2098481087 hasAuthorship W2098481087A5045085140 @default.
• W2098481087 hasAuthorship W2098481087A5086995715 @default.
• W2098481087 hasAuthorship W2098481087A5089712382 @default.
• W2098481087 hasAuthorship W2098481087A5091227500 @default.
• W2098481087 hasConcept C148001335 @default.
• W2098481087 hasConcept C169760540 @default.
• W2098481087 hasConcept C170493617 @default.
• W2098481087 hasConcept C185592680 @default.
• W2098481087 hasConcept C2778186239 @default.
• W2098481087 hasConcept C2778938600 @default.
• W2098481087 hasConcept C2780871563 @default.
• W2098481087 hasConcept C46721173 @default.
• W2098481087 hasConcept C55493867 @default.
• W2098481087 hasConcept C71924100 @default.
• W2098481087 hasConcept C86803240 @default.
• W2098481087 hasConcept C89951826 @default.
• W2098481087 hasConcept C93248783 @default.
• W2098481087 hasConcept C98274493 @default.
• W2098481087 hasConceptScore W2098481087C148001335 @default.
• W2098481087 hasConceptScore W2098481087C169760540 @default.
• W2098481087 hasConceptScore W2098481087C170493617 @default.
• W2098481087 hasConceptScore W2098481087C185592680 @default.
• W2098481087 hasConceptScore W2098481087C2778186239 @default.
• W2098481087 hasConceptScore W2098481087C2778938600 @default.
• W2098481087 hasConceptScore W2098481087C2780871563 @default.

• next